Development of human antigen-presenting cells expressing peptide-loadable ''empty'' class I alleles for use in tumor vaccines.

被引：0
|
作者：
Hanlon, D [1 ]
Lee, C [1 ]
Berger, C [1 ]
Cresswell, P [1 ]
Edelson, R [1 ]
机构：
[1] YALE UNIV,DEPT DERM & IMMUNOL,NEW HAVEN,CT 06520
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1997年 / 108卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：166 / 166
页数：1
相关论文
共 19 条
  • [1] A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells
    Cunningham, AC
    Zhang, JG
    Moy, JV
    Ali, S
    Kirby, JA
    IMMUNOLOGY, 1997, 91 (03) : 458 - 463
  • [2] Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments
    Gaubin, M
    Fanutti, C
    Mishal, Z
    Durrbach, A
    De Berardinis, P
    Sartorius, R
    Del Pozzo, G
    Guardiola, J
    Perham, RN
    Piatier-Tonneau, D
    DNA AND CELL BIOLOGY, 2003, 22 (01) : 11 - 18
  • [3] MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy
    Possamai, David
    Hanafi, Laila-Aicha
    Bellemare-Pelletier, Angelique
    Hamelin, Katia
    Thebault, Pamela
    Hebert, Marie-Josee
    Gagnon, Etienne
    Leclerc, Denis
    Lapointe, Rejean
    PLOS ONE, 2021, 16 (12):
  • [4] Cytomegalovirus interleukin-10 expression in infected cells does not impair MHC class I restricted peptide presentation on bystanding antigen-presenting cells
    Pepperl-Klindworth, S
    Besold, K
    Frankenberg, N
    Farkas, M
    Kuball, J
    Theobald, M
    Plachter, B
    VIRAL IMMUNOLOGY, 2006, 19 (01) : 92 - 101
  • [5] TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells
    Liu, TM
    Chambers, B
    Diehl, AD
    Van Kaer, L
    Jondal, M
    Ljunggren, HG
    JOURNAL OF IMMUNOLOGY, 1997, 159 (11): : 5364 - 5371
  • [6] Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex ''re-presentation'' of exogenous antigen by tumor-infiltrating antigen-presenting cells
    Pulaski, BA
    Yeh, KY
    Shastri, N
    Maltby, KM
    Penney, DP
    Lord, EM
    Frelinger, JG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) : 3669 - 3674
  • [7] Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4+ T cells
    Garnier, Anthony
    Hamieh, Mohamad
    Drouet, Aurelie
    Leprince, Jerome
    Vivien, Denis
    Frebourg, Thierry
    Le Mauff, Brigitte
    Latouche, Jean-Baptiste
    Toutirais, Olivier
    IMMUNOLOGY AND CELL BIOLOGY, 2016, 94 (07): : 662 - 672
  • [8] Coadministration of IL-12 obviates the need to use dendritic cells in tumor antigen peptide-pulsed antigen-presenting cell (APC) vaccination.
    Fallarino, F
    Ashikari, A
    Gajewski, TF
    FASEB JOURNAL, 1998, 12 (05): : A908 - A908
  • [9] MHC class II-presented peptide repertoires derived from human antigen-presenting cells pulsed with blood coagulation factor VIII
    van Haren, S. D.
    Herczenik, E.
    ten Brinke, A.
    Mertens, K.
    Meijer, A.
    Voorberg, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 269 - 269
  • [10] Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells
    Sethumadhavan, Shalini
    Silva, Murillo
    Philbrook, Phaethon
    Thao Nguyen
    Hatfield, Stephen M.
    Ohta, Akio
    Sitkovsky, Michail V.
    PLOS ONE, 2017, 12 (11):
12